Search

everythinglearnresearchcommunity

for

Search:↓

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Targeting Midkine can help reduce pain and itching in keloids.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

ZPK helps skin cells mature and may affect skin health.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

New molecules can prevent cell death in hair follicles.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.